ArgusEye specializes in innovative sensor solutions that enable real-time monitoring and control of biological systems and processes. Their patented technology integrates nanoplasmonic sensing with fiber optics, allowing for specific in-line analysis that was previously limited to off-line methods. This advancement aims to transform the development and production of biologics by providing rapid and accurate quality data, which is essential for the biopharmaceutical industry. The Auga™ platform, a key offering from ArgusEye, is designed to facilitate seamless integration into existing production equipment, thereby enhancing the efficiency of both upstream and downstream bioprocessing.

The sensor chips utilized in the Auga™ platform are crafted from medical-grade stainless steel, ensuring improved biocompatibility and integration capabilities. These chips are functionalized with various ligands to provide specificity and selectivity for detecting a wide range of analytes, including proteins and antibodies. By employing a versatile surface chemistry, ArgusEye's sensor chips minimize non-specific binding and deliver reliable real-time data for biomolecular interactions. This technology not only enhances the monitoring of critical process parameters but also supports the biopharma industry's need for rapid development and production of biological drugs, ultimately addressing the growing demand for effective therapies.

Sweden

ArgusEye provides innovative sensor systems based on nanoplasmonic detection for real-time monitoring of biological systems and processes.

ArgusEye

Company Details